In the first 120 days of 2018, Balkan Pharmaceuticals has registered 9 new drugs and re-registered 2 medicinal products. New drugs include Etoposide-BP, Furosemid-BP, but also the irreplaceable product – Water for injections, solvent for parenteral use. The expansion of the range of manufactured medicines is one of the main goals of Balkan Pharmaceuticals, which contributes to ensuring the pharmaceutical security of the Republic of Moldova and diminishing the dependence on imported drugs.
